{
    "id": 143,
    "name": "BREAST-CANCER-INHIBITORS",
    "url-publication": "https://doi.org/10.1158/0008-5472.CAN-21-1208",
    "url-model": "https://github.com/jgtz/BreastCancerModelv2/blob/e018f50344b378e57f36ba9fcceda6611f2a71b8/Models/BreastCancerModel_ZanudoEtAl2020.sbml",
    "keywords": [
        "curated",
        "repaired"
    ],
    "variables": 71,
    "inputs": 26,
    "regulations": 223,
    "notes": "### Modifications\n\nConstant update functions of variables `Alpelisib`, `Everolimus`, `Trametinib`, `BCL2_T`, `BCLXL_T`, `MCL1_T`, `BIM_T`, `ER`, `ER_microenvironment`, `FOXA1`, `Fulvestrant`, `HER2`, `HER3_T`, `HER3_microenvironment`, `Ipatasertib`, `MYC_T`, `Navitoclax`, `Neratinib`, `PBX1`, `PDK1`, `PIM`, `Palbociclib`, `Rb_T`, `S63845`, `SGK1_T`, and `p27_T` were removed to make them canonical inputs. Finally, variables `E2F_3`, `pRb_3` and `Proliferation_4` were removed because they are unused.",
    "bib": "@article{bbm-143,\n\ttitle={Cell Line--Specific Network Models of ER+ Breast Cancer Identify Potential PI3K$\\alpha$ Inhibitor Resistance Mechanisms and Drug Combinations},\n\tauthor={G{\\'o}mez Tejeda Za{\\~n}udo, Jorge and Mao, Pingping and Alcon, Clara and Kowalski, Kailey and Johnson, Gabriela N and Xu, Guotai and Baselga, Jose and Scaltriti, Maurizio and Letai, Anthony and Montero, Joan and others},\n\tjournal={Cancer research},\n\tvolume={81},\n\tnumber={17},\n\tpages={4603--4617},\n\tyear={2021},\n\tpublisher={AACR}\n}"
}